Kobayashi Pharmaceutical Co. Ltd (KOY F) stock market data APIs
€28.86
0(0%)
as of January 16, 2026
Try our APIs with
free plan!
Kobayashi Pharmaceutical Co. Ltd Financial Data Overview
Price chart is built with
Anychart
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, sanitary and paper products, hand warmers, aloe products, displays, models, mouthpieces, and kaiko; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, and asset management activities. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Prev. Close
28.86
Open
28.86
High
28.86
Low
28.86
52 wk Range
27.0871-35.3156
Market Cap
2 197 M
P/E Ratio
34.0476
Shares Outstanding
74 339 K
Revenue
163 179 M
Dividends (Yield)
0.0203
Beta
0.282
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kobayashi Pharmaceutical Co. Ltd data using free add-ons & libraries
Get Kobayashi Pharmaceutical Co. Ltd Fundamental Data
Kobayashi Pharmaceutical Co. Ltd Fundamental data includes:
- Net Revenue: 163 179 M
- EBITDA: 28 863 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kobayashi Pharmaceutical Co. Ltd News
New
Court Proceedings Begin in Oasis’s Shareholder Derivative Lawsuit Seeking Director Accountability for Kobayashi Pharmaceutical Beni-Koji Supplement Tragedy
(Securities Code: 4967 JT) *The first shareholder derivative lawsuit hearing takes place today at Osaka District Court *Oasis seeks to hold directors accountable for the Beni-Koji incident and to he...
How Does Kobayashi Pharma Stack Up After Its 2024 Profit Warning?
Thinking about whether to buy, hold, or sell Kobayashi Pharmaceutical stock? You're not alone. Every investor knows the feeling: looking at a company that’s been in the headlines and wondering if th...
Voting Cards Reveal that Over 50% of Shareholders Excluding the Founding Family and Related Parties Voted For Oasis’s EGM Proposals and Against Mr. Akihiro Kobayashi’s Renomination at the AGM
Details of the founding family related partiesApproval rates for proposals at the extraordinary general meeting of shareholdersApproval rates for Agenda 1 at the annual general meeting of shareholders...
Oasis Files Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors
(Securities Code: 4967 JT) *On April 3, 2025, Oasis filed a shareholder derivative lawsuit with the Osaka District Court against the Directors of Kobayashi Pharmaceutical *The lawsuit is related to ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
